Header image

Who we are

Quantori delivers end-to-end digital and AI-driven solutions, empowering innovation in the life sciences and healthcare industries.

Accelerating Drug Discovery
and Patient Outcomes

Quantori is the premier digital services partner for life sciences and healthcare companies worldwide. With deep domain expertise and end-to-end capabilities in AI, data science, and software engineering, we help biopharma innovators accelerate R&D pipelines and bring transformative therapies to patients across the globe.
Woman with glasses

Our
mission

Our mission is to build custom solutions, from traditional platforms to advanced AI-driven systems, that solve today’s challenges and give our clients a competitive advantage in innovative, science-focused fields.

OUR CORE VALUES
Our core values are the principles we embody every day, shaping our work, collaborations, and contributions. They form the essence of Quantori's culture and serve as the compass that guides us on our journey, making a positive impact on the industry and the world we operate in.
Integrity
Guided by Principles,
Driven by Purpose
Integrity is the foundation of trust, fostering strong relationships with our partners, clients, and team members.
Dignity
Where Respect
Meets Progress
We uphold the belief that every individual should receive dignified and respectful treatment nurturing an inclusive and supportive work environment.
Empathy
Building Solutions
That Begin with Understanding
Empathy fuels collaboration enabling us to forge deeper connections and cultivate a workplace characterized by compassion and understanding.
Accountability
Driving Progress,
Delivering Results
Accountability ensures the fulfillment of our commitments, with reflections and learnings from challenges faced, and driving continuous improvement.
Innovation
Innovating Today
for a Better Tomorrow
Innovation fuels our growth, enabling us to pioneer solutions that have a significant impact on the life sciences healthcare and pharma industries.
Executive Leadership
End-to-end main solutions image

Leaders in Digital IT and AI-Driven Services

Our team of 500+ solutions-focused data scientists, data engineers, and thought leaders has been at the forefront of life sciences and healthcare IT for over 30 years. By combining deep domain knowledge with advanced AI capabilities and real-world experience, we deliver customized solutions to meet the most complex challenges.

Abstract background waves
500+
Solutions-Focused:
Vaccine illustration

Where Innovation
Happens

Quantori’s headquarters in Cambridge, Massachusetts provides a front-row seat to breakthroughs in life sciences and healthcare. We attract top talent from leading academic institutions and continue to grow at an exciting pace. Our partnerships with biotech and pharmaceutical leaders have established us the provider of choice for AI-powered and custom software solutions at every stage of development.
Yuriy Gankin Quantori
Yuriy Gankin, PhD
Chief Scientific Officer

Yuriy Gankin, Ph.D., is a business leader, serial entrepreneur, life sciences researcher, inventor, and mentor who has over two decades of expertise in helping life science technology, scientific publishing, biotech, and global pharmaceutical companies to improve informatics solutions to accelerate the discovery and development of novel drug therapies.

At Quantori, Yuriy leads the company’s efforts to provide domain expertise in life sciences and healthcare and directs the company’s initiatives to develop domain-specific proprietary and open-source platforms and solutions.

Previously, Yuriy was a Chief Life Sciences Officer and Vice President of the Life Sciences Business Unit at EPAM, following the acquisition of GGA Software Services by EPAM. As GGA co-founder, Yuriy helped build the company into a leading provider of scientific software engineering, algorithm development, and data curation services for the life sciences and healthcare sectors.

Earlier in his career, Yuriy co-founded SciVision, a leading developer of informatics solutions for life science technology and pharmaceutical companies. SciVision developed multiple innovative molecular modeling and de-novo design applications. It was acquired by Harcourt Brace Jovanovich in 1997.

Yuriy also co-founded Felicitex, an innovative pharma company developing a platform targeting cancer resistance, metastasis, and relapse, in 2015. Yuriy provides his scientific and business expertise as a board director of Felicitex Therapeutics.

Yuriy’s research has been published in multiple peer-reviewed papers and holds several patents for analytical chemistry and targeted cancer therapy. Yuriy holds a Ph.D. in Analytical Chemistry from Tufts University and an EMBA from the MIT Sloan School of Management.